COMMUNIQUÉS West-GlobeNewswire

Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company
23/06/2026
Press Release Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company Shareholder loan agreement for up to €6.0 million over 3 years Company is currently well-financed, [...]
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
23/06/2026
Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses Cenrifki represents a significant advancement for people [...]
argenx to Host Autoimmune Myositis R&D Webinar
23/06/2026
June 23, 2026, 7:00 AM CET Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, will host a [...]
Communiqué de presse : Cenrifki (tolebrutinib) de Sanofi approuvé dans l’UE comme premier médicament ciblant la progression du handicap dans la sclérose en plaques secondairement progressive sans rechutes
23/06/2026
Cenrifki (tolebrutinib) de Sanofi approuvé dans l’UE comme premier médicament ciblant la progression du handicap dans la sclérose en plaques secondairement progressive sans rechutes Cenrifki représente une avancée [...]
BienRaíz Launches Vitamin D3 5000 IU Softgels: A High-Potency, Simple Formula for Everyday Wellness
23/06/2026
New Vitamin D3 Supplement Delivers 5000 IU of Cholecalciferol in Easy-to-Take Softgels Designed for Adults Seeking a Flexible Daily Wellness Routine LOS ANGELES, June 23, 2026 (GLOBE NEWSWIRE) -- As more adults spend [...]
COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment
23/06/2026
TORONTO, ONTARIO, June 22, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) announced the next steps in connection with changes to the Company’s share capital [...]
Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/06/2026
SAN MATEO, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
22/06/2026
CONSHOHOCKEN, Pa., June 22, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
22/06/2026
BOSTON and LONDON, June 22, 2026 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other [...]
CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
22/06/2026
BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced the closing [...]
Transactions of Managers and Closely Associated Persons
23/06/2026
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 10,133,333 [...]
Pioneering screening test offers potential to find more aggressive prostate cancers
22/06/2026
Annals of Internal Medicine publishes study showing potential benefits of Stockholm3 in identifying patients with aggressive prostate cancer STOCKHOLM, June 22, 2026 (GLOBE NEWSWIRE) -- A3P Biomedical, a diagnostics [...]
MoonLake Immunotherapeutics Announces Proposed Public Offering
22/06/2026
ZUG, Switzerland, June 22, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases, today [...]
Tango Therapeutics Appoints Robert Azelby to Board of Directors
22/06/2026
BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today [...]
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders
22/06/2026
TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the “ [...]
Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast
22/06/2026
GARDEN CITY, N.Y., June 22, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/06/2026
BEDFORD, Mass., June 22, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
22/06/2026
ALAMEDA, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. ( NASDAQ: VANI ) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, [...]
uniQure Announces $150 Million Proposed Public Offering
22/06/2026
LEXINGTON, Mass. and AMSTERDAM, June 22, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced [...]

Pages